Purinergic mechanisms in breast cancer support intravasation, extravasation and angiogenesis.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cancer Letters

• Publication date

  2010-05-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.canlet.2009.09.021PMID 19926395PMCID PMC2849889
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The hallmarks of cancer

  2012cited by this paper
• Adenosine receptors and cancer.

  2011cited by this paper
• Purinergic receptor‐mediated effects of adenosine 5′‐triphosphate in urological malignant diseases

  2009cited by this paper
• Nucleoside diphosphate kinase (NDPK, NM23, AWD): recent regulatory advances in endocytosis, metastasis, psoriasis, insulin release, fetal erythroid lineage and heart failure; translational medicine exemplified

  2009cited by this paper
• Subcellular localization of Nm23/NDPK A and B isoforms: a reflection of their biological function?

  2009cited by this paper
• A new approach to the inflammatory/autoimmune diseases.

  2009cited by this paper
• Purinergic regulation of vascular endothelial growth factor signaling in angiogenesis

  2009cited by this paper
• Endothelial signaling in paracellular and transcellular leukocyte transmigration.

  2009cited by this paper
• Erythrocytes: oxygen sensors and modulators of vascular tone.

  2009cited by this paper
• Cancer Statistics, 2009

  2009cited by this paper
• Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype.

  2009cited by this paper
• Strategies to enhance the efficacy of intravescical therapy for non-muscle invasive bladder cancer.

  2009cited by this paper
• Modes of resistance to anti-angiogenic therapy

  2008cited by this paper
• A clinicopathological study of nm23-H1 expression in classical Hodgkin's lymphoma.

  2008cited by this paper
• Effects of Extracellular ATP on Bovine Lung Endothelial and Epithelial Cell Monolayer Morphologies, Apoptoses, and Permeabilities

  2008cited by this paper
• Regulation of coronary blood flow during exercise.

  2008cited by this paper
• The effects of surgery on tumor growth: a century of investigations.

  2008cited by this paper
• Intravital Microscopic Characterization of Suramin Effects in an Orthotopic Immunocompetent Rat Model of Pancreatic Cancer

  2008cited by this paper
• Phase I/II trial of 5-fluorouracil and a noncytotoxic dose level of suramin in patients with metastatic renal cell carcinoma.

  2008cited by this paper
• Inhibition of Nm23H2 gene product (NDPK-B) by angiostatin, polyphenols and nucleoside analogs.

  2008cited by this paper
• Effect of blood flow on near-the-wall mass transport of drugs and other bioactive agents: a simple formula to estimate boundary layer concentrations.

  2008cited by this paper
• Dormancy and surgery‐driven escape from dormancy help explain some clinical features of breast cancer  

  2008cited by this paper
• The natural history of invasive breast cancers detected by screening mammography.

  2008cited by this paper
• Clinical biomarkers of angiogenesis inhibition

  2008cited by this paper
• Novel therapeutic options in metastatic renal cancer - review and post ASCO 2007 update.

  2008cited by this paper
• Breaching the basement membrane: who, when and how?

  2008cited by this paper
• Use of the Monoclonal Antibody Anti-HER2 Trastuzumab in the Treatment of Metastatic Breast Cancer: A Cost-Effectiveness Analysis

  2008cited by this paper
• Cancer survival in five continents: a worldwide population-based study (CONCORD).

  2008cited by this paper
• Extracellular ATP and Cancer—An Overview with Special Reference to P2 Purinergic Receptors

  2008cited by this paper
• The importance of distant metastases in hormone-sensitive breast cancer.

  2008cited by this paper
• P2 receptors in cardiovascular regulation and disease

  2007cited by this paper
• Purinergic regulation of angiogenesis by human breast carcinoma-secreted nucleoside diphosphate kinase

  2007cited by this paper
• Stepping out of the flow: capillary extravasation in cancer metastasis

  2007cited by this paper
• Autocrine VEGF signaling is required for vascular homeostasis.

  2007cited by this paper
• Molecular modeling of the human P2Y2 receptor and design of a selective agonist, 2'-amino-2'-deoxy-2-thiouridine 5'-triphosphate.

  2007cited by this paper
• Overview of resistance to systemic therapy in patients with breast cancer.

  2007cited by this paper
• Nucleotide P2Y1 receptor regulates EGF receptor mitogenic signaling and expression in epithelial cells

  2007cited by this paper
• Nm23-H1 homologs suppress tumor cell motility and anchorage independent growth

  2007cited by this paper
• Suramin Inhibits Not Only Tumor Growth and Metastasis but Also Angiogenesis in Experimental Pancreatic Cancer

  2007cited by this paper
• Current status in human breast cancer micrometastasis

  2007cited by this paper
• Angiogenesis inhibitors. Drug selectivity and target specificity.

  2007cited by this paper
• Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures

  2007cited by this paper
• Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice.

  2007cited by this paper
• P2y receptor-mediated angiogenesis via vascular endothelial growth factor receptor 2 signaling.

  2007cited by this paper
• New signals from the invasive front

  2006cited by this paper
• P2 receptors and cancer.

  2006cited by this paper
• ATP Release From Activated Neutrophils Occurs via Connexin 43 and Modulates Adenosine-Dependent Endothelial Cell Function

  2006cited by this paper
• Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis.

  2006cited by this paper
• ATP participates in the regulation of microvessel permeability

  2006cited by this paper
• Nucleotide metabolism and cell-cell interactions.

  2006cited by this paper
• The natural history of ductal carcinoma in situ of the breast: a review

  2006cited by this paper
• Purinergic signalling

  2006cited by this paper
• Pathophysiology and Therapeutic Potential of Purinergic Signaling

  2006cited by this paper
• Lessons from phase III clinical trials on anti-VEGF therapy for cancer

  2006cited by this paper
• Translational approaches using metastasis suppressor genes

  2006cited by this paper
• Organ-specific metastatic tumor cell adhesion and extravasation of colon carcinoma cells with different metastatic potential.

  2006cited by this paper
• P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: effects of extracellular nucleotides on apoptosis and cell proliferation.

  2005cited by this paper
• NO mediates mural cell recruitment and vessel morphogenesis in murine melanomas and tissue-engineered blood vessels.

  2005cited by this paper
• The natural history of low‐grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long‐term follow‐up

  2005cited by this paper
• Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs.

  2005cited by this paper
• Bevacizumab: improved survival at what cost?

  2005cited by this paper
• Does Vasculogenic Mimicry Exist in Astrocytoma?

  2005cited by this paper
• Modulation of endothelial cell migration by extracellular nucleotides

  2005cited by this paper
• Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment.

  2005cited by this paper
• Novel Role of ARF6 in Vascular Endothelial Growth Factor–Induced Signaling and Angiogenesis

  2005cited by this paper
• Clinical significance of serum NM23‐H1 protein in neuroblastoma

  2005cited by this paper
• Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.

  2005cited by this paper
• (-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis.

  2004cited by this paper
• Vascular endothelial growth factor: basic science and clinical progress.

  2004cited by this paper
• Molecular recognition at purine and pyrimidine nucleotide (P2) receptors.

  2004cited by this paper
• Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors

  2004cited by this paper
• Assembly and patterning of vertebrate blood vessels.

  2004cited by this paper
• The P2Y2 Nucleotide Receptor Mediates Vascular Cell Adhesion Molecule-1 Expression through Interaction with VEGF Receptor-2 (KDR/Flk-1)*

  2004cited by this paper
• P2Y receptor-mediated Ca(2+) signaling increases human vascular endothelial cell permeability.

  2004cited by this paper
• Nucleoside diphosphate kinase (NDPK/NM23) and the waltz with multiple partners: Possible consequences in tumor metastasis

  2004cited by this paper
• GFP-transfected tumor cells are useful in examining early metastasis in vivo, but immune reaction precludes long-term tumor development studies in immunocompetent mice

  2004cited by this paper
• The impact of preoperative breast biopsy on the risk of sentinel lymph node metastases: analysis of 2502 cases from the Austrian sentinel node biopsy study group

  2004cited by this paper
• Structure-activity relationships of synthetic analogs of (-)-epigallocatechin-3-gallate as proteasome inhibitors.

  2004cited by this paper
• Manipulation of the primary breast tumor and the incidence of sentinel node metastases from invasive breast cancer.

  2004cited by this paper
• Recent translational research: computational studies of breast cancer

  2004cited by this paper
• Localization of VEGFR-2 and PLD2 in endothelial caveolae is involved in VEGF-induced phosphorylation of MEK and ERK.

  2004cited by this paper
• Role of Estrogen Receptor in the Regulation of Ecto-5′-Nucleotidase and Adenosine in Breast Cancer

  2004cited by this paper
• VEGF receptor signal transduction.

  2003cited by this paper
• Nucleotide coronary vasodilation in guinea pig hearts.

  2003cited by this paper
• Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol.

  2003cited by this paper
• Multiple Biochemical Activities of NM23/NDP Kinase in Gene Regulation

  2003cited by this paper
• Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response.

  2003cited by this paper
• P2Y receptor‐mediated enhancement of permeation requires Ca2+ signalling in vascular endothelial cells

  2003cited by this paper
• Measurement of adenine nucleotides in plasma.

  2003cited by this paper
• Angiogenesis: Tumorigenesis and the angiogenic switch

  2003cited by this paper
• P2Y-receptor regulates size of endothelial cells in an intracellular Ca2+ dependent manner.

  2003cited by this paper
• Extracellular ATP as a signaling molecule for epithelial cells.

  2003cited by this paper
• Molecular regulation of vessel maturation

  2003cited by this paper
• Persistence of microscopic human cancers in mice: alterations in the angiogenic balance accompanies loss of tumor dormancy

  2002cited by this paper
• Mechanisms of cancer drug resistance.

  2002cited by this paper
• Tumor‐infiltrating endothelial cells and endothelial precursor cells in inflammatory breast cancer

  2002cited by this paper
• Expression of cell surface NM23 proteins of human leukemia cell lines of various cellular lineage and differentiation stages.

  2002cited by this paper
• P2 Receptor Expression Profiles in Human Vascular Smooth Muscle and Endothelial Cells

  2002cited by this paper
• Vasculogenic mimicry and pseudo‐comedo formation in breast cancer

  2002cited by this paper
• Nucleotide‐mediated relaxation in guinea‐pig aorta: selective inhibition by MRS2179

  2002cited by this paper

• The purinergic signaling interfaces in breast cancer angiogenesis

  2026influential citation
• Ectonucleotidases: Possible roles in the tumor microenvironment and influence on tumor progression in breast cancer.

  2026cites this paper
• An emerging master inducer and regulator for epithelial-mesenchymal transition and tumor metastasis: extracellular and intracellular ATP and its molecular functions and therapeutic potential

  2023cites this paper
• Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: The prime suspect in cancer therapeutic resistance

  2022cites this paper
• ATP and Adenosine Metabolism in Cancer: Exploitation for Therapeutic Gain

  2022cites this paper
• Targeting the purinergic pathway in breast cancer and its therapeutic applications

  2021cites this paper
• Cell-adhesion molecules as key mechanisms of tumor invasion: the case of breast cancer.

  2021cites this paper
• Adenosine metabolism in the vascular system.

  2020cites this paper
• Chemoresistance in Breast Cancer Patients Associated With Changes in P2X7 and A2A Purinergic Receptors in CD8+ T Lymphocytes

  2020cites this paper
• Evaluating the effect of Avastin on breast cancer angiogenesis using synchrotron radiation.

  2019cites this paper
• A system for detecting high impact-low frequency mutations in primary tumors and metastases

  2018cites this paper
• Exosome Mediated Purinergic Mechanisms in Breast Cancer

  2018cites this paper
• Advanced biomaterials and microengineering technologies to recapitulate the stepwise process of cancer metastasis.

  2017cites this paper
• Papel do receptor P2X7 e da enzima CD39/NTPDASE1 na resposta à radioterapia em gliomas

  2016cites this paper
• Rethinking NM23: An Extracellular role for NDPKinase in breast cancer

  2015cites this paper
• Docosahexaenoic acid inhibits the invasion of MDA-MB-231 breast cancer cells through upregulation of cytokeratin-1.

  2015cites this paper
• Enzymes involved in metabolism of extracellular nucleotides and nucleosides: Functional implications and measurement of activities

  2014cites this paper
• A comparative analysis of surgical treatment to primary tumor in patients with metastatic breast cancer

  2014cites this paper
• The Role of Aquaporin 3 (AQP3) in Breast Cancer

  2014cites this paper
• Nutrient Transport in the Mammary Gland: Calcium, Trace Minerals and Water Soluble Vitamins

  2014cites this paper
• Differentiating connexin hemichannels and pannexin channels in cellular ATP release

  2014cites this paper
• Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?

  2013cites this paper
• Purinergic signalling and cancer

  2013cites this paper
• RESPONSE OF TRIPLE NEGATIVE BREAST CANCER CELLS TO

  2012cites this paper
• Molecular networks that regulate cancer metastasis.

  2012cites this paper
• Targeting tumor metastasis by regulating Nm23 gene expression.

  2012cites this paper
• Hypoxia and Hypoxia-Inducible factors in Breast Cancer: Targeting Breast Cancer Stem Cells

  2012cites this paper
• UNIVERSIDADE FEDERAL DE SANTA MARIA CENTRO DE CIÊNCIAS NATURAIS E EXATAS PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS BIOLÓGICAS: BIOQUÍMICA TOXICOLÓGICA

  2011cites this paper
• Extracellular NM23 Protein as a Therapeutic Target for Hematologic Malignancies

  2011influential citation
• A role for nucleotides in support of breast cancer angiogenesis: heterologous receptor signalling

  2011cites this paper
• Extracellular NM23 Signaling in Breast Cancer: Incommodus Verum

  2011cites this paper
• Andrographolide inhibits human umbilical vein endothelial cell invasion and migration by regulating MMP-2 and MMP-9 during angiogenesis.

  2011cites this paper
• A role of epithelial-mesenchymal transitions in carcinogenic progression

  2011cites this paper
• Avaliação do padrão temporal no catabolismo do ATP extracelular : possível modulação noradrenérgica

  2010cites this paper
• 24-HOUR TEMPORAL PATTERN OF NTPDase AND 5′-NUCLEOTIDASE ENZYMES IN RAT BLOOD SERUM

  2010cites this paper
• Surgery Triggers Outgrowth of Latent Distant Disease in Breast Cancer: An Inconvenient Truth?

  2010cites this paper
• Measurement of human breast tumor cell-secreted shNDPK-B in a murine breast cancer model suggests its role in metastatic progression.

  2009cites this paper